Winthrop Partners - WNY’s ResMed RMD Stock Holding History

Winthrop Partners - WNY’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100	Closed	-$9.46K	–	343
2018 Q1	$9.46K	Buy	+100	New	+$9.45K	0.01%	339

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Winthrop Partners - WNY's RMD Position: Q2 2018 in Review

Winthrop Partners - WNY sold out of ResMed (RMD) in Q2 2018, closing a stake of 100 shares — an estimated $9.46K sold.

Winthrop Partners - WNY first reported a position in RMD in Q1 2018 and held it in 1 quarter. The position peaked at $9.46K in Q1 2018. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

Winthrop Partners - WNY reported no remaining ResMed position as of Q2 2018 after selling out during the quarter.
Winthrop Partners - WNY sold 100 ResMed shares in Q2 2018, an estimated $9.46K.
Winthrop Partners - WNY first reported a position in ResMed in Q1 2018 and held it in 1 quarter.
Winthrop Partners - WNY's ResMed position peaked at $9.46K in Q1 2018.
465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on Winthrop Partners - WNY's 13F filing for Q2 2018, filed 30 Jul 2018.